Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
Citation: Journal for ImmunoTherapy of Cancer 2014 2(Suppl 3):P104
Page 1 of 1
Sort by: Relevance | Date
Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. However, the molecular mechanisms underneath the anti-cancer effect, if any,...